Target intelligence / Profile preview

Long intergenic non-protein coding RNA 659 (LINC00659)

Target
LINC00659
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 659 (LINC00659) is a long non-coding RNA categorized as a long intergenic non-coding RNA (lincRNA); it does not code for a protein and is primarily involved in transcriptional and post-transcriptional regulation of gene expression. LINC00659 is upregulated in several cancers, particularly gastric and colon cancer, where it is associated with cancer progression, metastasis, and poor prognosis. Mechanistically, LINC00659 may serve as a competing endogenous RNA by binding and sequestering tumor-suppressive microRNAs such as miR-370, thus facilitating the expression of pro-tumorigenic genes including AQP3, and it can regulate pathways such as PI3K-AKT to influence proliferation and apoptosis. Its expression has also been linked to epithelial-mesenchymal transition, cell migration, and invasion in cancer cells. LINC00659 is being explored as a prognostic biomarker and a potential therapeutic target in oncology.

Other names
LINC00659long intergenic non-coding RNA 659lincRNA 659
02

Mechanism of action

Functions as a miRNA sponge (ceRNA), for example sponging miR-370 in gastric cancer, leading to upregulation of downstream genes such as AQP3. Modulates PI3K-AKT signaling pathway in colon cancer cells.

03

Biological functions

Regulation of gene expressionCompeting endogenous RNA (ceRNA) activityCell migrationEpithelial-mesenchymal transitionModulation of cell cycle and apoptosis in some contexts
04

Disease associations

Cancer (including gastric cancer, colon cancer)
05

Safety considerations

Potential challenges and safety issues are not directly described, but as a non-coding RNA, therapeutic targeting may involve delivery and specificity barriers
06

Biomarkers

Prognostic marker for gastric cancer progression and poor outcome

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 659 (LINC00659).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 659 (LINC00659).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call